Tibra Equities Europe Ltd Acquires Shares of 13,300 Agilent Technologies Inc (NYSE:A)

Tibra Equities Europe Ltd acquired a new stake in Agilent Technologies Inc (NYSE:A) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 13,300 shares of the medical research company’s stock, valued at approximately $1,019,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Edgestream Partners L.P. acquired a new position in Agilent Technologies during the second quarter valued at approximately $2,616,000. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its holdings in shares of Agilent Technologies by 81.0% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 157,403 shares of the medical research company’s stock valued at $11,753,000 after acquiring an additional 70,426 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of Agilent Technologies by 2.6% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 66,135 shares of the medical research company’s stock valued at $4,938,000 after acquiring an additional 1,654 shares during the period. HighTower Advisors LLC lifted its holdings in Agilent Technologies by 1,183.0% in the second quarter. HighTower Advisors LLC now owns 122,800 shares of the medical research company’s stock worth $9,132,000 after purchasing an additional 113,229 shares during the period. Finally, Prentiss Smith & Co. Inc. lifted its holdings in Agilent Technologies by 484.9% in the second quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock worth $4,363,000 after purchasing an additional 48,438 shares during the period.

Several equities research analysts recently weighed in on the stock. Bank of America downgraded shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a report on Tuesday, July 16th. Barclays dropped their price target on shares of Agilent Technologies from $78.00 to $76.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 9th. Robert W. Baird reiterated an “outperform” rating and issued a $82.00 price target (up from $79.00) on shares of Agilent Technologies in a research report on Thursday, August 15th. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Finally, Piper Jaffray Companies boosted their price target on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $84.00.

NYSE A traded up $0.11 on Friday, hitting $76.02. 374,184 shares of the company were exchanged, compared to its average volume of 1,400,664. The company’s 50 day moving average price is $75.74 and its 200-day moving average price is $72.83. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72. The firm has a market capitalization of $23.38 billion, a P/E ratio of 27.25, a price-to-earnings-growth ratio of 1.88 and a beta of 1.42. Agilent Technologies Inc has a twelve month low of $62.00 and a twelve month high of $82.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.04. The firm had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.24 billion. Agilent Technologies had a return on equity of 20.00% and a net margin of 21.06%. The business’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.67 EPS. As a group, equities analysts expect that Agilent Technologies Inc will post 3.08 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were paid a $0.164 dividend. The ex-dividend date was Monday, September 30th. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. Agilent Technologies’s payout ratio is 23.66%.

In other Agilent Technologies news, Director Heidi Fields sold 4,000 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $70.96, for a total transaction of $283,840.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 24,635 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $77.50, for a total value of $1,909,212.50. The disclosure for this sale can be found here. Insiders have sold 32,635 shares of company stock valued at $2,507,293 in the last ninety days.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Reverse Stock Split

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply